Drug Type Gene therapy |
Synonyms- |
Target- |
Mechanism Gene transference |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Glioblastoma | Phase 1 | US | 07 Mar 2016 | |
Gliosarcoma | Phase 1 | US | 07 Mar 2016 | |
Oligodendroglioma | Phase 1 | US | 07 Mar 2016 | |
Recurrent WHO Grade II Glioma | Phase 1 | US | 07 Mar 2016 | |
WHO Grade III Mixed Glioma | Phase 1 | US | 07 Mar 2016 |
Phase 1 | 18 | (Dose Level 1: 5x10^7 (1 Dose)) | qhrakbhaiw(perhgjgbgr) = ixyjficuib ucsopzfift (ukopoknpnz, jjmpdqnivm - tjywlxbumn) View more | - | 29 Apr 2024 | ||
(Dose Level 2: 5x10^7 (2 Doses)) | qhrakbhaiw(perhgjgbgr) = yddchvsaho ucsopzfift (ukopoknpnz, bmdpxmqxni - pcdvpphabg) View more |